Literature DB >> 28162808

FGF13 Selectively Regulates Heat Nociception by Interacting with Nav1.7.

Liu Yang1, Fei Dong1, Qing Yang2, Pai-Feng Yang3, Ruiqi Wu4, Qing-Feng Wu1, Dan Wu1, Chang-Lin Li1, Yan-Qing Zhong1, Ying-Jin Lu1, Xiaoyang Cheng5, Fu-Qiang Xu4, Limin Chen6, Lan Bao7, Xu Zhang8.   

Abstract

The current knowledge about heat nociception is mainly confined to the thermosensors, including the transient receptor potential cation channel V1 expressed in the nociceptive neurons of dorsal root ganglion (DRG). However, the loss of thermosensors only partially impairs heat nociception, suggesting the existence of undiscovered mechanisms. We found that the loss of an intracellular fibroblast growth factor (FGF), FGF13, in the mouse DRG neurons selectively abolished heat nociception. The noxious heat stimuli could not evoke the sustained action potential firing in FGF13-deficient DRG neurons. Furthermore, FGF13 interacted with the sodium channel Nav1.7 in a heat-facilitated manner. FGF13 increased Nav1.7 sodium currents and maintained the membrane localization of Nav1.7 during noxious heat stimulation, enabling the sustained firing of action potentials. Disrupting the FGF13/Nav1.7 interaction reduced the heat-evoked action potential firing and nociceptive behavior. Thus, beyond the thermosensors, the FGF13/Nav1.7 complex is essential for sustaining the transmission of noxious heat signals.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FGF13; brain imaging; heat nociception; sensory neuron; sodium channel; thermosensor

Mesh:

Substances:

Year:  2017        PMID: 28162808     DOI: 10.1016/j.neuron.2017.01.009

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  27 in total

Review 1.  Mining the Nav1.7 interactome: Opportunities for chronic pain therapeutics.

Authors:  Lindsey A Chew; Shreya S Bellampalli; Erik T Dustrude; Rajesh Khanna
Journal:  Biochem Pharmacol       Date:  2019-01-27       Impact factor: 5.858

2.  5'-UTR SNP of FGF13 causes translational defect and intellectual disability.

Authors:  Xingyu Pan; Jingrong Zhao; Zhiying Zhou; Jijun Chen; Zhenxing Yang; Yuxuan Wu; Meizhu Bai; Yang Jiao; Yun Yang; Xuye Hu; Tianling Cheng; Qianyun Lu; Bin Wang; Chang-Lin Li; Ying-Jin Lu; Lei Diao; Yan-Qing Zhong; Jing Pan; Jianmin Zhu; Hua-Sheng Xiao; Zi-Long Qiu; Jinsong Li; Zefeng Wang; Jingyi Hui; Lan Bao; Xu Zhang
Journal:  Elife       Date:  2021-06-29       Impact factor: 8.140

3.  Cytokine activin C ameliorates chronic neuropathic pain in peripheral nerve injury rodents by modulating the TRPV1 channel.

Authors:  Ya-Kun Huang; Yu-Gang Lu; Xin Zhao; Jing-Bing Zhang; Feng-Ming Zhang; Yong Chen; Ling-Bo Bi; Jia-Hui Gu; Zuo-Jie Jiang; Xiao-Man Wu; Qing-Yi Li; Yanli Liu; Jian-Xin Shen; Xing-Jun Liu
Journal:  Br J Pharmacol       Date:  2020-11-16       Impact factor: 8.739

4.  Ionic Mechanisms of Impulse Propagation Failure in the FHF2-Deficient Heart.

Authors:  David S Park; Akshay Shekhar; John Santucci; Gabriel Redel-Traub; Sergio Solinas; Shana Mintz; Xianming Lin; Ernest Whanwook Chang; Deven Narke; Yuhe Xia; Mitchell Goldfarb; Glenn I Fishman
Journal:  Circ Res       Date:  2020-09-23       Impact factor: 17.367

5.  FGF13 Is Required for Histamine-Induced Itch Sensation by Interaction with NaV1.7.

Authors:  Fei Dong; Haixiang Shi; Liu Yang; Huaqing Xue; Manyi Wei; Yan-Qing Zhong; Lan Bao; Xu Zhang
Journal:  J Neurosci       Date:  2020-11-10       Impact factor: 6.167

6.  Differential Inhibition of Nav1.7 and Neuropathic Pain by Hybridoma-Produced and Recombinant Monoclonal Antibodies that Target Nav1.7 : Differential activities of Nav1.7-targeting monoclonal antibodies.

Authors:  Sangsu Bang; Jiho Yoo; Xingrui Gong; Di Liu; Qingjian Han; Xin Luo; Wonseok Chang; Gang Chen; Sang-Taek Im; Yong Ho Kim; Judith A Strong; Ma-Zhong Zhang; Jun-Ming Zhang; Seok-Yong Lee; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2018-01-15       Impact factor: 5.203

Review 7.  Development of Allosteric Modulators of Voltage-Gated Na+ Channels: A Novel Approach for an Old Target.

Authors:  Nolan M Dvorak; Paul A Wadsworth; Pingyuan Wang; Jia Zhou; Fernanda Laezza
Journal:  Curr Top Med Chem       Date:  2021       Impact factor: 3.295

8.  Fibroblast growth factor 13 stabilizes microtubules to promote Na+ channel function in nociceptive DRG neurons and modulates inflammatory pain.

Authors:  Qiong Wang; Jing Yang; Handong Wang; Bin Shan; Chengyu Yin; Hang Yu; Xuerou Zhang; Zishan Dong; Yulou Yu; Ran Zhao; Boyi Liu; Hailin Zhang; Chuan Wang
Journal:  J Adv Res       Date:  2020-12-17       Impact factor: 10.479

9.  CRISPR/Cas9 editing of Nf1 gene identifies CRMP2 as a therapeutic target in neurofibromatosis type 1-related pain that is reversed by (S)-Lacosamide.

Authors:  Aubin Moutal; Xiaofang Yang; Wennan Li; Kerry B Gilbraith; Shizhen Luo; Song Cai; Liberty François-Moutal; Lindsey A Chew; Seul Ki Yeon; Shreya S Bellampalli; Chaoling Qu; Jennifer Y Xie; Mohab M Ibrahim; May Khanna; Ki Duk Park; Frank Porreca; Rajesh Khanna
Journal:  Pain       Date:  2017-12       Impact factor: 7.926

10.  Knockout of the X-linked Fgf13 in the hypothalamic paraventricular nucleus impairs sympathetic output to brown fat and causes obesity.

Authors:  Daniel S Sinden; Corey D Holman; Curtis J Bare; Xiaolu Sun; Aravind R Gade; David E Cohen; Geoffrey S Pitt
Journal:  FASEB J       Date:  2019-07-24       Impact factor: 5.834

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.